Literature DB >> 15744129

Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.

Sarah Newton1, Yanli Ding, Chun-Shiang Chung, Yaping Chen, Joanne L Lomas-Neira, Alfred Ayala.   

Abstract

BACKGROUND: Sepsis remains a substantial risk after surgery or other trauma. Macrophage dysfunction, as a component of immune suppression seen during trauma and sepsis, appears to be one of the contributing factors to morbidity and mortality. However, whereas it is known that the ability of macrophages to present antigen and express major histocompatibility complex MHC class II molecules is decreased during sepsis, it is not known to what extent this is associated with the loss of co-stimulatory receptor expression. Our objectives in this study were, therefore, to determine if the expression of co-stimulatory molecules, such as CD40, CD80, or CD86, on peritoneal/splenic/liver macrophages were altered by sepsis (cecal ligation [CL] and puncture [CLP] or necrotic tissue injury (CL) alone; and to establish the contribution of such changes to the response to septic challenge using mice that are deficient in these receptors.
METHODS: To address our first objective, male C3H/HeN mice were subjected to CLP, CL, or sham (n = four to six mice/group), and the adherent macrophages were isolated from the peritoneum, spleen, or liver at 24 h post-insult. The macrophages were then analyzed by flow cytometry for their ex vivo expression of CD40, CD80, CD86, and/or MHC II.
RESULTS: The expression of CD86 and MHC II, but not CD40 or CD80, were significantly decreased on peritoneal macrophages after the onset of sepsis or CL alone. In addition, CD40 expression was significantly increased in Kupffer cells after sepsis. Alternatively, splenic macrophages from septic or CL mice did not show changes in the expression of CD80, CD86, or CD40. To the degree that the loss of CD86 expression might contribute to the changes reported in macrophage function in septic mice, we subsequently examined the effects of CLP on CD86 -/- mice. Interestingly, we found that, unlike the background controls, neither the serum IL-10 concentrations nor the IL-10 release capacity of peritoneal macrophages from septic CD86 -/- mice were increased.
CONCLUSION: Together, these data suggest a potential role for the co-stimulatory receptor CD86/B7-2 beyond that of simply promoting competent antigen presentation to T-cells, but also as a regulator of the anti-inflammatory IL-10 response. Such a role may implicate the latter response in the development of sepsis-induced immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15744129      PMCID: PMC2253680          DOI: 10.1089/sur.2004.5.375

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  38 in total

1.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.

Authors:  L L Lanier; S O'Fallon; C Somoza; J H Phillips; P S Linsley; K Okumura; D Ito; M Azuma
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

2.  Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production.

Authors:  A Ayala; Z K Deol; D L Lehman; C D Herdon; I H Chaudry
Journal:  J Surg Res       Date:  1994-06       Impact factor: 2.192

3.  Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).

Authors:  A Ayala; M M Perrin; J M Kisala; W Ertel; I H Chaudry
Journal:  Circ Shock       Date:  1992-03

Review 4.  Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes.

Authors:  A Ayala; W Ertel; I H Chaudry
Journal:  Shock       Date:  1996-02       Impact factor: 3.454

5.  Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen.

Authors:  A Ayala; M M Perrin; P Wang; W Ertel; I H Chaudry
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

6.  Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis.

Authors:  A Ayala; J B Knotts; W Ertèl; M M Perrin; M H Morrison; I H Chaudry
Journal:  Arch Surg       Date:  1993-01

7.  Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release.

Authors:  A Ayala; M M Perrin; W Ertel; I H Chaudry
Journal:  Cytokine       Date:  1992-01       Impact factor: 3.861

8.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor.

Authors:  T J Standiford; R M Strieter; N W Lukacs; S L Kunkel
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Is sepsis-induced apoptosis associated with macrophage dysfunction?

Authors:  A Ayala; M A Urbanich; C D Herdon; I H Chaudry
Journal:  J Trauma       Date:  1996-04

10.  Alteration of mononuclear cell immune-associated antigen expression, interleukin-1 expression, and antigen presentation during intra-abdominal infection.

Authors:  R N Gallinaro; W Naziri; K M McMasters; J C Peyton; W G Cheadle
Journal:  Shock       Date:  1994-02       Impact factor: 3.454

View more
  18 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.

Authors:  Nicholas J Shubin; Chun S Chung; Daithi S Heffernan; Lydea R Irwin; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

Review 3.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

4.  CD80 Regulates Th17 Cell Differentiation in Coxsackie Virus B3-Induced Acute Myocarditis.

Authors:  Yanlan Huang; Yong Li; Bin Wei; Weifeng Wu; Xingcui Gao
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

5.  Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari.

Authors:  Marco A Quevedo-Diaz; Chang Song; Yanbao Xiong; Haiyan Chen; Larry M Wahl; Suzana Radulovic; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2010-07-08       Impact factor: 4.962

6.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis.

Authors:  Anna Nolan; Michael Weiden; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Nehal Mehta; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

8.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

9.  Downregulation of CD40 ligand response in monocytes from sepsis patients.

Authors:  Anna Sinistro; Cristiana Almerighi; Chiara Ciaprini; Silvia Natoli; Emanuele Sussarello; Sara Di Fino; Francesca Calò-Carducci; Giovanni Rocchi; Alberto Bergamini
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

10.  Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis.

Authors:  Anna Nolan; Hiroshi Kobayashi; Bushra Naveed; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Matthew R Karulf; William N Rom; Michael D Weiden; Jeffrey A Gold
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.